ArticleDrug design, development and therapy2022

Combined Treatment of Tanshinone I and Epirubicin Revealed Enhanced Inhibition of Hepatocellular Carcinoma by Targeting PI3K/AKT/HIF-1α.

Jiali Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.